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24% (427) and positive in 12% (213). There were no adverse effects of IET. There were 
1608 Pts with O-1 ACF and 176 with 2-3 ACF. MultIpIe ACF predicted a positive or ND 
IET: 2 ACF (RR 4.2, Cl 2.6-6.3) and 3 ACF (RR 2.7, Cl 0.8-9.0). At 30 day FU there were 
no deaths and total cardiac events (non-Q Ml + revascularization) were: Pts with O-l ACF 
- 1.7%; Pts with 2-3 ACF - 7.0%. Revascularizatlon comprised 81% (30137) of all events. 
CONCLUSION: Aggregation of ACF is associated wth an increase in positive IET and 
cardiac events. However, there were no deaths and the number of events was very low, 
the majority of which were revascularization. Patients with ACF can be safely managed 
by the accelerated protocol in our CPEU. 
1072-l 03 Decline in Recurrent lschemic Events After Myocardial 
infarction: A 20-Year Community Study 
Maan Jokhadar, Steven J. Jacobsen, Guy S. Reeder, Susan A. Weston, Ryan 
Meverden, Jill M. Killian, Veronique L. Roger, Mayo Clinic, Rochester, MN 
Background: Despite use of efficacious interventions for secondary prevention after 
myocardial infarction (MI), little is known about their effect on the long-term incidence of 
recurrent ischemic events after Ml. This study tested the hypothesis that recurrent 
lschemic events after incident Ml declined over time. 
Methods: Standard epidemiological criteria were used to validate all incident MIS in Olm- 
sted County between 1979 and 1996. Recurrent ischemic events defined as recurrent 
MI. unstable angina requiring hospitalization (UA) and sudden cardiac death (SCD), were 
idenbfied through the community medical record. 
Results: Between 1979 and 1998, 2277 incident Ml cases occurred I” Olmsted County 
(57% men; mean age, 672 14 years). After 6.3i 5.3 years of follow-up, there were 566 
recurrent MIS, 1025 UA, and 230 SCDs. The B-year event-free survival was 77% (95% 
Cl, 75%-79%) for recurrent MI, 53% (95% Cl%, 51.55%) for UA, and 93% (95% Cl, 92%. 
94%) for SCD. 
The table presents the relative risk (RR) of recurrent ischemlc events over time using 
subjects with Ml between 1979 and 1963 as the referent. Overall, all recurrent ischemic 
events decreased over bme, in earlier years largely due to decline in recurrent Ml and UA 
whereas in most recent years, a marked decline in SCD occurred. 
Conclusion: Over the past 2 decades, the occurrence of recurrent lschemic events after 
incident Ml declined over time. most likely reflecting advances in therapy and secondary 
prevention. 
sion had occurred asymptomatically. 
Conclusions: After demonstrated coronary patency following fibrinolytic therapy, 
patients who survived the first 48 hours had an excellent IO-year prognosis. Whereas 
reocclusion was associated with a markedly increased risk of cardiac mortality, even in 
case of asymptomatic reocclus~on. all cause mortality did not differ from patients with 
sustained patency. 
1072-101 Management and Outcomes of Patients With Acute 
Coronary Syndromes: One-Year Results From the 
Canadian Acute Coronary Syndrome Registry 
Andrew T. Yan Shaun G. Goodman, Mary Tan. David Fltchett, Chi-Ming Chow, Anatoly 
Langer, Canadian ACS Registry Investigators, University of Toronto and Canadian Healt 
Research Centre, Toronto, ON, Canada 
Background: While clinical trials provide evidence for the management of acute core- 
nary syndromes (ACS), these results may not be applicable to a wider patient population. 
There are limited data regarding the actual management and outcomes of patients dis- 
charged from hospitals following an ACS. 
Methods: The ACS Registry IS a prospective Canadian observational study of 5312 
patients wth suspected ACS from 51 centres in 9 provinces. A final diagnosis of ACS 
was determined in 4627 patients (87.1%). Vital status at l-year was available for 4329 
patients (6% lost to follow-up). Non-fatal cardiac events (myccardial infarction=Ml; unsta- 
ble angina=UA), angiography, and revascularization (percutaneous coronary interven- 
tion=PCI; coronary bypass surgery=CABG) after discharge (via standardized telephone 
intervwv) were recorded for 3844 hospital discharge survivors at I-year follow-up. 
Results: One-year cumulative mortality was 9.2%. Treatment and unadjusted outcomes 
post-discharge for 3844 hospital swivors, classified by index discharge ACS diagnosis, 
were as follows: 
Post-discharge to 1 All Q Wave Ml Non-Q MI UA (41%) 
year patients (27%) (32%) 
Death 7.2% 6.5% 10%’ 5.4% 
(re) MI 2.9% 2.7% 3.7% 2.6% 
Unstable Angina 8.0% 5.8% 6.4% 11%’ 
Angiography 14% 15% 13% 14% 
PCI 6.8% 6.6% 6.6% 7.2% 
CABG 3.9% 4.3% 4.3% 3.3% 
* p< 0.001 
Conclusions: Despite similar rates of in-hospital and post-discharge coronary angiogra- 
phy and revascularuation. unadjusted l-year mortality was higher in patients with non-Q 
wave Ml. This suggests that more aggressive therapy, including re-allocation of limited 
resources towards management of these high-risk patients, may be required. 
1072-102 Multiple Clinical Risk Factors Do Not Preclude 
Immediate Exercise Testing in a Chest Pain Evaluation 
Unit 
Ezra A. Amsterdam, Deborah Diercks, J. Douglas Kirk, University of California, Davis, 
Medical Center, Sacramento, CA 
BACKGROUND: In pabents (Pts) presenting with chest pain suggestive of acute coro- 
nary syndrome (ACS), low risk is associated with a nonischemic imtial electrocardiogram 
and negative serum cardiac marker. To further refine risk assessment of these Pts. addi- 
tional clinical factors (ACF) have been utilized, as in the TIMI risk score. It has been sug- 
gested that Pts with aggregation of these risk factors should not be evaluated by an 
accelerated protocol in a chest pain evaluation unit (CPEU) because of a higher rats of 
ACS in this group. In our CPEU, we employ immediate exercise testing (IET) in Pts con- 
sidered low or intermediate risk based on the initial ECG and cardiac serum marker. We, 
therefore, reviewed our experience in Pts with ACF. 
METHODS: All Pts admItted to the CPEU had a normal initial ECG and negative initial 
serum troponin I or myoglobln. We determlned the relationship to Pt outcome of 2 1 of 
the following ACF: previously documented coronary artery disease, advanced age (>65 
yr) and presence of 2 3 CAD risk factors. Final diagnosis of ACS was based on evidence 
of CAD by further cardiac study (stress imaging or angiography) or occurrence of myo- 
cardlal InfarctIon, revascularization or cardiac death during CPEU stay or 30 day follow- 
up (FU) period. 
RESULTS: IET was performed in 1808 consecutive Pts (919 men, 889 women. mean 
age 54 yr.) and was negative for lschemla in 65% (1168) of Pts. non-diagnostic (ND) in 
RR of recurrent ischemic events after MI in different time periods 
1979. 1984-1988 1989-l 993 1994-l 998 
1963 
Recurrent MI 
1 .oo 0.85 0.76 0.79 
(Cl 0.68-l .07) (Cl 0.60-0.96) (Cl 0.62-1.02) 
Unstable angina 
1 .oo 0.84 0.93 0.81 
(Cl 0.71-1.01) (Cl 0.78-1.10) (Cl 0.68-0.97) 
SCD 
1.00 1.04 0.87 0.40 
(Cl 0.75-l .45) (Cl 0.61-I .26) (Cl 0.24-0.67) 
Any event 
1 .oo 0.89 0.89 0.76 
(Cl 0.76-1.04) (Cl 0.76-1.04) (Cl 0.66-0.93) 
1072-104 The TIMI Risk Index Predicts Long-Term Mortality in 
Patients Admitted With Primary Unstable Angina 
David O’Halloran Christopher J. O’Donnell. Robert P. Giugliano, Carlos A. Camargo, Jr., 
Larry Allen, Donald M. Lloyd-Jones, Massachusetts General Hospital, Boston, MA 
Background:The Thrombolysis In Myocardial lschemia (TIMI) risk index - [(heart rate x 
(agellO~)isystolic blood pressure] has been shown to be a strong and independent 
predictor of 30.day mortality in selected patients presenting with ST-elevation MI, but its 
utility for unselected patients presenting with unstable angina (UA) and its ability to pre- 
dict long term outcomes are unknown. 
Methods: We updated a pre-existing database of 280 unselected patients with primary 
UA admitted via the Emergency Department to a large, urban academic hospital in 1991- 
1992. We calculated the TIMI risk index for each patient based on values at presentation 
and used Cox models to assess the ability of the risk Index to predict long-term mortality. 
Results: There were 275 patients (age 66+12 years, 33% women) who survived to hos- 
pital discharge. Post-discharge death was documented in 134 patients. VItaI status was 
known for >99% of patients at 1 year, 86% at 5 years and 77% at 10 years. Median fol- 
low-up for patients who did not die was 9.4 years. The mean risk index was 23tlO points 
(range 5-65). The risk index was a strong predictor of l-year and lo-year mortality 
(p=O.OOZ). For each lo-point increase in the risk index, the hazard ratio for one year mor- 
tality was 1.61 (95% Cl 1.23 - 2.10) and the hazard ratio for 10 year mortality was 1.72. 
(95% Cl 1.51 - 1.96). We found optimal discrimination for 1 O-year mortality using a cut- 
point of 21 points (=21 vs. ~21: hazard ratio (HR) 4.3, 95% Cl 2.9-6.4). Compared with 
the lowest quintile of risk index, the HR for lo-year mortality for the highest qulntile was 
5.5 (95% Cl 3.0-10.0). After multivariable adjustment for other known predictors of lo- 
year mortality (CHF. elevated creatinine or kukocytosis at presentation, history of diabe- 
tes mellitus or Ml), the risk index remained a significant predictor of 1 O-year moltality (HR 
for lo-point increase: 1.5, 95% Cl 1.3-l 3). 
